Skip to main content
Log in

The role of complement-derived mediators in inflammatory skin diseases

  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Summary

The complement system represents an important nonspecific skin defense mechanism. Its activation leads to the generation of products that not only help to maintain normal host defenses but also mediate inflammation and tissue injury. Proinflammatory products of complement include large fragments of C3 with opsonic and cell-stimulatory activities (C3b and C3bi), low molecular weight anaphylatoxins (C3a, C4a, and C5a), and membrane attack complex. Among them C5a or its degradation product C5a des Arg seems to be the most important mediator because it exerts a potent chemotactic effect on inflammatory cells. Intradermal administration of C5a anaphylatoxin induces skin changes quite similar to those observed in cutaneous hypersensititivy vasculitis that occurs through immune complex-mediated complement activation. Complement activation is involved in the pathogenesis of the inflammatory changes in autoimmune bullous dermatoses. In pemphigus complement activation by pemphigus antibody in the epidermis seems to be responsible for the development of characteristic inflammatory changes termed eosinophilic spongiosis. In bullous pemphigoid (BP) interaction of basement membrane zone antigen and BP antibody leads to complement activation that seems to be related to leukocytes lining the dermoepidermal junction. Resultant anaphylatoxins not only activate the infiltrating leukocytes but also induce mast cell degranulation which facilitates dermoepidermal separation and eosinophil infiltration. Similar complement activation seems to play a more direct role in the dermoepidermal separation noted in epidermolysis bullosa acquisita and herpes gestationis. Anaphylatoxin generation via the alternative pathway activation under ligth irradiation is implicated in the development of the immediate erythematous phototoxic reactions induced by such well-known chemicals as porphyrin, chlorthiazide, demethylchlortetracycline, and chlorpromazine. It is known that a direct exposure of the stratum corneum to living skin tissues induces intense infammatory changes. In vitro study demonstrated that the stratum corneum activates complement via the antibody-independent alternative pathway to generate C5a anaphylatoxin. Thus, accumulated horny material from the follicular wall seems to play a crucial role in the induction of pustules in inflammatory acne lesions and abscesses in ruptured epidermal cysts via the activation of the alternative complement pathway. Meanwhile, in search for the chemotactic factors responsible for the transepidermal leukocyte chemotaxis noted in psoriasis and related sterile pustular dermatoses, we have detected the presence of unique chemotactic peptides in the scale extracts of lesional skin. Later studies identified the presence of C5a des Arg and IL-8 in this peptide fraction. The alternative complement pathway has been speculted for the complement activation at the subcorneal portion of the psoriatic epidermis by further immunological studies. Similar properties to activate the alternative complement pathway have been noted in various pathogenic fungi that induce inflammatory skin lesions. Generation of C5a anaphylatoxin beneath the fungus-laden stratum corneum seems to be responsible for the characteristic subcorneal pustule formation in superficial infections such as cutaneous candidiasis and dermatophytosis, whereas that around fungal spores in the dermis is presumed to play a role in the induction of mixed cell granuloma characterized by a dense neutrophil infiltration as noted in sporotrichosis and chromomycosis. AlthoughPityrosporum ovale constitutes ordinary skin microflora in seborrheic areas, its properties which activate complement via the alternative pathway are implicated in the pathogenesis of dandruff and seborrheic dermatitis, in which transepidermal neutrophil chemotaxis as noted in psoriasis is observed histopathologically.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Belew PW, Rosenberg EW, Jennings BR (1980) Activation of the alternative pathway of complement byMalassezia ovalis (Pityrosporum ovale). Mycopathologia 70: 187–190

    Google Scholar 

  2. Beutner EH, Jarzabek-Chorzelska M, Jablonska S, Chorzelski TP, Rzesa G (1978) Autoimmunity in psoriasis. A complement immunofluorescence study. Arch Dermatol Res 261: 123–134

    Google Scholar 

  3. Briggaman RA, Schechter NM, Fraki J. Lazarus GS (1984) Degradation of the epidermal-dermal junction by proteolytic enzymes from human skin and human polymorphonucler leukocytes. J Exp Med 160: 1027–1042

    Google Scholar 

  4. Dahl MGC, McGjibbon DH (179) Complement C3 an dimmunoglobulin in inflammtory acne vulgaris. Br J Dermatol 101: 633–640

    Google Scholar 

  5. Dahl MV, Lindroos WE, Nelson RD (1978) Chemokinetic and chemotactic factors in psoriasis scale extracts. J Invest Dermatol 71: 402–406

    Google Scholar 

  6. Dalback K, Lofberg H, Dalback B (1986) Localization of vitronectin (S-protein of complement) in normal human skin. Acta Derm Venerol (Stockh) 66: 461–467

    Google Scholar 

  7. Dalziel K, Dykes PJ, Marks R (1984) Inflammation due to intracutaneous implantation of stratum corneum. Br J Exp Pathol 65: 107–125

    Google Scholar 

  8. Emmerson RW, Wilson Jones E (1968) Eosinophilic spongiosis in pemphigus. Arch Dermatol 97: 252–267

    Google Scholar 

  9. Fincham NJ, Camp RDR, Gearing AJH, Bird CR, Cunningham FM (1988) Neutrophil chemoattractant and IL-1-like activity in samples from psoriatic lesions: further characterization. J Immunol 140: 4249–4299

    Google Scholar 

  10. Gammon WR, Lewis DM, Carlo JR, Sams WM Jr. Wheeler CE (1980) Pemphigoid antibody mediated attachment of peripheral blood leukocytes at the dermal-epidermal junction of human skin. J Invest Dermatol 75: 334–339

    Google Scholar 

  11. Gammon WR, Inman AO III, Wheeler CE Jr (1984) Differences in complement-dependent chemotactic acitivity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes, demonstration by leukocyte attachment and organ culture methods. J Invest Dermatol 83: 57–61

    Google Scholar 

  12. Gigli I (1981) The complement system. Mechanisms of action, biology, and participation in dermatological diseases. In: Safai B, Good RA (eds) Immunodermatology. Plenum, New York, pp 65–100

    Google Scholar 

  13. Goldstein IM (1988) Complement: biologically active products In: Gallin JI, Goldstein IM, Snyderman R (ed) Inflammation. Basic principles and clinical correlates. Raven, New York, pp 55–74

    Google Scholar 

  14. Hashimoto T, Sugiura M, Kurihara S, Nishikawa T (1982) In vitro complement activation by intercellular antibodies. J Invest Dermatol 78: 316–318

    Google Scholar 

  15. Hashimoto K, Jensen PJ, Lazarus GS (1989) In vitro studies of acantholysis of keratinocytes induced by pemphigus antibody. In: Norris DA (eds) Immune mechanisms in cutaneous disease. Marcel Dekker, New York, pp 277–290

    Google Scholar 

  16. Iwatsuki K, Tagami H, Yamada M (1983) Induction of leukocyte adherence at the basement membrane zone with subsequent activation of their metabolic pathway by pemphigoid antibodies and complement. Acta Derm Venereol (Stockh) 63: 290–295

    Google Scholar 

  17. Iwatsuki K, Tagami H, Yamada M (1983) Pemphigus antibodies mediate the development of inflammatory change in the epidermis. Acta Derm Venereol (Stockh) 63: 495–500

    Google Scholar 

  18. Jungi T, McGregor DD (1979) Role of complement in the expression of delayed-type hypersensitivity in rats: studies with cobra venom factor. Infect Immun 23: 633–643

    Google Scholar 

  19. [Reference deleted]

  20. Kaneko J, Gushiken H, Kawagishi M, Miura Y, Kobayashi K, Konno T (1980) Analysis of immunological responses in psoriatic lesions. I. Immunopathological studies on psoriatic lesions. J Invest Dermatol 1980; 75: 436–439

    Google Scholar 

  21. Kato T, Terui T, Takematsu H, Tagami H (1989) Effects of psoriatic scale extracts on oxidative metabolic responses in granulocytes assessed by chemiluminescence. Inflammation 13: 59–66

    Google Scholar 

  22. Katz SI, Hertz KC, Yaoita H (1976) Herpes gestationis: immunopathology and characterization of the HG factor. J Clin Invest 57: 1434–1441

    Google Scholar 

  23. Kawana S, Geoghegan WD, Jordon RE (1985) Complement fixation by pemphigus antibody. II. Complement enhanced detachment of epidermal cells. Clin Exp Immunol 61: 517–525

    Google Scholar 

  24. Kikuchi, T, Horii I, Sakamoto T, Nakayama Y, Tagami H (1989) Demonstration of neutrophil chemotactic anaphylatoxins in human dandruff. Arch Dermatol Res 281: 482–486

    Google Scholar 

  25. Krogh HK (1969) Antibodies in human sera to stratum corneum. Int Arch Allergy 36: 415–426

    Google Scholar 

  26. Leeming JP, Ingham E, Cunliffe WJ (1988) The microbial content and complement C3 cleaving capacity of comedones in acne vulgaris. Acta Derm Venereol (Stockh) 68: 468–473

    Google Scholar 

  27. Lim HW, Gigli J (1981) The role of complement in phototoxic reactions. Springer Semin Immunopathol 4: 209–219

    Google Scholar 

  28. Lim HW, Perez HD, Poh-Fizpatrick M, Goldstein IM, Gigli I (1981) Generation of chemotactic activity in serum from patients with erythorpoietic protoporphyria and porphyria cutanea tarda. N Engl J Med 304: 212–216

    Google Scholar 

  29. Lim HW, Novotny H, Gigli I (1983) Role of complement and polymorphonuclear cells in demethylchlortetracycline-induced phototoxicity in guinea pigs inhibited by decomplementation in vivo. J Clin Invest 71: 1326–335

    Google Scholar 

  30. Lim HW, He D, Esquenazi-Behar S, Yancey KB, Soter NA (1991). C5a cutaneous mast cells and inflammation in vitro and in vitro studies in murine models. J Invest Dermatol 97: 305–311

    Google Scholar 

  31. Maibach HI, Kligman AM (1962) The biology of experimental human cutaneous moniliasis. Arch Dermatol 85: 233–257

    Google Scholar 

  32. Marley WM, Belew PW, Rosenberg EW, Urmson JR, Stizel E, Spitzer RE (1982) Abnormalities in the alternative pathway of complement in psoriasis. Clin Exp Dermatol 7: 387–396

    Google Scholar 

  33. Müller-Eberhardt HJ (1984) The membrane attack complex. Springer Semin Immunopathol 7: 93–141

    Google Scholar 

  34. Naito K, Morioka S, Ikeda S, Ogawa H (1984) Experimental bullous pemphigoid in guinea pigs: the role of pemphigoid antibodies complement, and migrating cells. J Invest Dermatol 82: 227–230

    Google Scholar 

  35. Norris JFB, Cunliffe WJ (1988) A histological and immunocytochemical study of early acne lesions. Br J Dermatol 118: 651–659

    Google Scholar 

  36. Ohkhochi K, Takematsu H, Tagami H (1985) Increased anaphylatoxins (C3a and C4a) in psoriatic sera. Br J Dermatol 113: 189–196

    Google Scholar 

  37. Ohkhochi K, Takematsu H, Tagami H (1986) Determination of anaphylatoxin concentrations in suction blisters in patients with psoriasis. J Invest Dermatol 87: 65–67

    Google Scholar 

  38. Ohkhochi K, Torinuki W, Tagami H (1989) Plasma concentrations of complement-modulating proteins (C1 inhibitor, C4 binding protein, factor H and factor I) in inflammatory dermatoses with special reference to psoriasis. Dermatologica 179: 30s-34s

    Google Scholar 

  39. Pinkus H, Mehregan AH (1966) The primary histologic lesion of seborrheic dermatitis and psoriasis. J Invest Dermatol 46: 109–116

    Google Scholar 

  40. Rauterberg A, Jung EG, Burger R, Rauterberg EW (1990) Phototoxic erythema following PUVA treatment: independence of complement. J Invest Dermatol 94: 144–149

    Google Scholar 

  41. Ray TL, Wuepper KD (1976) Activation of the alternative (properdin) pathway of complement byCandida albicans and related species. J Invest Dermatol 67: 700–703

    Google Scholar 

  42. Ray TL, Wuepper KD (1978) Experimental cutaneous candidiasis in rodents. II. Role of the stratum corneum barrier and serum complement as a mediator of a protective inflammatory response. Arch Dermatol 114: 539–543

    Google Scholar 

  43. Rosenberg EW, Noah PW, Wyatt RJ, Jones RM, Kolb WP (1990) Complement activation in psoriasis. Clin Exp Dermatol 15: 16–20

    Google Scholar 

  44. Sayama K, Shiraishi S, Shirakata Y, Kobayashi Y, Miki Y (1991) Characterization of decay-accelerating factor (DAF) in human skin. J Invest Dermatol 96: 61–64

    Google Scholar 

  45. Schröder J-M (1992) Generation of NAP-1 and related peptides in psoriatic and other inflammatory skin diseases. In: Baggiolini M, Sorg C (eds) Interleukin-8 (NAP-1) and related chemotactic cytokines, vol. 4. Cytokines, Karger, Basel, pp 54–76

    Google Scholar 

  46. Schröder J-M, Christophers E (1985) Transient absence of C5a-specific neutrophil function in inflammatory disorders of the skin. J Invest Dermatol 85: 194–198

    Google Scholar 

  47. Scott D, Cunliffe W, Gowland G (1979) Activation of complement — a mechanism for the inflammation in acne. Br J Dermatol 101: 315–320

    Google Scholar 

  48. Shuster S (1984) The aetiology of dandruff and the mode of action of therapeutic agents. Br J Dermatol 111: 235–242

    Google Scholar 

  49. Sohnle PG, Hahn BL (1989) Epidermal proliferation and the neutrophilic infiltrates of experimantal cutaneous candidiasis in mice. Arch Dermatol Res 281: 279–283

    Google Scholar 

  50. Swan JW, Dahl MV, Coppo PA, Hammerschmidt DE (1983) Complement activation byTrichophyton rubrum. J Invest Dermatol 80: 156–158

    Google Scholar 

  51. Swerlick RA, Yancey KB, Lawley T (1988) A direct in vivo comparison of the inflammatory properties of human C5a and C5a des Arg in human skin. J Immunol 140: 2376–2381

    Google Scholar 

  52. Tagami H (1985) Epidermal cell proliferationin guinea pigs with experimental dermatophytosis. J Invest Dermatol 85: 153–155

    Google Scholar 

  53. Tagami H, Imamura S, Noguchi S, Nishitani H (1976) Coexistence of peculiar pemphigus, myasthenia gravis and malignant thymoma. Dermatologica 152: 181–190

    Google Scholar 

  54. Tagami H, Ofuji S (1976) Leukotactic properties of soluble substances in psoriasis scale. Br J Dermatol 95: 1–8

    Google Scholar 

  55. Tagami H, Ofuji S (1977) Characterization of a leukotactic factor derived from psoratic scale. Br J Dermatol 97: 509–511

    Google Scholar 

  56. Tagami H, Watanabe S, Ofuji S, Minami K (1977) Trichophytin contact sensitivity in patients with dermatophytosis. Arch Dermatol 113: 1409–1414

    Google Scholar 

  57. Tagami H, Ofuji S (1978) A leukotactic factor in the stratum corneum of pustulosis palmaris et plantaris: a possible mechanism for the formation of intra-epidermal strerile pustules. Acta Derm Venereol (Stockh) 58: 401–405

    Google Scholar 

  58. Tagami H, Natsume N, Aoshima T, Yamada M (1982) Analysis of transepidermal leukocyte chemotaxis in experimental dermatophytosis in guinea pigs. Arch Dermatol Res 273: 205–217

    Google Scholar 

  59. Tagami H, Iwatsuki K, Iwase Y, Yamada M (1983) Subcorneal pustular dermatosis with vesiculo-bullous eruption Demonstration of IgA deposis at the intercellular portion of the upper epidermis and a leukocyte chemotactic factor. Br J Dermatol 109: 581–587

    Google Scholar 

  60. Tagami H, Iwatsuki K, Yamada M (1983) Profile of antistratum corneum autoantibodies in psoriatic patients. Arch Dermatol Res 275: 71–75

    Google Scholar 

  61. Tagami H, Urano-Suehisa S, Hatchome N (1985) Contact sensitivity toCandida albicans — comparative studies in man and animal (guinea pig). Br J Dermatol 113: 415–424

    Google Scholar 

  62. Takematsu H, Tagami H (1990) Activation of the alternative pathway of complement in psoriatic lesional skin. Dermatologica 181: 298–292

    Google Scholar 

  63. Takematsu H, Tagami H (1992) Preferential activation of the alternative pathway of complement in psoriatic lesional skin. Dermatology 184: 159–160

    Google Scholar 

  64. Takematsu H, Ohkohchi K, Tagami H (1986) Demonstration of anaphylatoxins (C3a, C4a and C5a) in the scale of psoriasis and inflammatory pustular dermatoses. Br J Dermatol 114: 1–6

    Google Scholar 

  65. Takematsu H, Terui T, Tagami H (1986) Demostration of leukotriene B4 in scale extracts of psoriasis and inflammatory pustular dermatoses. Correlation with leukocyte chemotactic activity and C5a anaphylatoxin. Acta Derm Venereol (Stockh) 66: 6–10

    Google Scholar 

  66. Takematsu H, Terui T, Ohkohchi K, Tagami H, Suzuki R, Kumagai K (1986) Presence of chemotactic peptides other than C5a anaphylatoxin in scales of psoriasis and sterile pustular dermatoses. Acta Derm Venereol (Stockh) 66: 93–97

    Google Scholar 

  67. Takematsu H, Terui T, Torinuki W, Tagami H (1987) Leukocyte chemotactic properties of soluble horny contents in epidermal cysts. Arch Dermatol Res 279: 449–453

    Google Scholar 

  68. Takematsu H, Isono N, Kato T, Tagami H (1990) Normal human epidermal keratinocyte-derived neutrophil chemotactic factor. Tohoku J Exp Med 162: 1–13

    Google Scholar 

  69. Terui T, Aiba S, Kato T, Tanaka T, Tagami H (1987) HLA-DR antigen expression on keratinocyte in highly inflamed parts of psoriatic lesions. Br J Dermatol 116: 87–93

    Google Scholar 

  70. Terui T, Rokugo M, Kato T, Tagami H (1989) Analysis of the pro-inflammatory property of epidermal cyst contents: chemotactic C5a anaphylatoxin generation. Arch Dermatol Res 281: 31–34

    Google Scholar 

  71. Terui T, Kato T, Tagami H (1989) Stratum corneum activation of complement through the antibody-independent alternative pathway. J Invest Dermatol 92: 593–597

    Google Scholar 

  72. Torinuki W, Tagami H (1985) Complement activation bySporotrix schenckii. Arch Dermatol Res 277: 332–333

    Google Scholar 

  73. Torinuki W, Tagami H (1986) The role of chlorpromazine-induced phototoxicity. J Invest Dermatol 86: 142–144

    Google Scholar 

  74. Torinuki W, Miura T, Tagami H (1984) Activation of the alternative complement pathway by 405 nm light in serum from porphyric rat. Acta Derm Venereol (Stockh) 64: 367–372

    Google Scholar 

  75. Torinuki W, Ohkohchi K, Takematsu H, Tagami H (1984) Activation of the alternative complement pathway byFonsecaea pedrosoi. J Invest Dermatol 83. 308–310

    Google Scholar 

  76. Webster G, Leyden J, Nilsson U (1979) Complement activation in acne vulgaris: consumption of complement by comedones. Infect Immun 26: 183–186

    Google Scholar 

  77. Werth VP, Ivanov IE, Nussenzweig V (1988) Decay-accelerating factor is associated with elastic fibers. J Invest Dermatol 91: 511–516

    Google Scholar 

  78. Yancey KB, Hammer CH, Harvath L, Renfer L, Frank MM, Lawley TJ (1985) Studies of human C5a as a mediator of inflammation in normal human skin. J Clin Invest 75: 486–495

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tagami, H. The role of complement-derived mediators in inflammatory skin diseases. Arch Dermatol Res 284 (Suppl 1), S2–S9 (1992). https://doi.org/10.1007/BF00638232

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00638232

Key words

Navigation